Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism USP8 inhibitors(ubiquitin specific peptidase 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H27N5O5 |
InChIKeyVNWOJNLRTJFWRQ-UHFFFAOYSA-N |
CAS Registry2410534-62-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | China | 05 Jul 2022 |